Clinical trial
Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
NCT00420355 · University of Oklahoma, Other · Terminated
Key facts
| NCT number | NCT00420355 |
|---|---|
| Title | Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients |
| Official title | The Pharmacokinetics of Lopinavir/Ritonavir in Combination With Atazanavir in HIV-Infected Subjects |
| Lead sponsor | University of Oklahoma, Other |
| Collaborators | Abbott Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | atazanavir, lopinavir/ritonavir |
| Enrollment | 19 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Jan 11, 2007 |
| Last update posted | Feb 6, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: